Ubiquitination and degradation of Syk and ZAP-70 protein tyrosine kinases in human NK cells upon CD16 engagement

Por Paolini, Rossella, Molfetta, Rosa, Piccoli, Mario, Frati, Luigi, Santoni, Angela
Publicado em 2001

Autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia is associated with IgVH status

Por Visco, Carlo, Novella, Elisabetta, Peotta, Eleonora, Paolini, Rossella, Giaretta, Ilaria, Rodeghiero, Francesco
Publicado em 2010

Regulation of Fc Receptor Endocytic Trafficking by Ubiquitination

Por Molfetta, Rosa, Quatrini, Linda, Gasparrini, Francesca, Zitti, Beatrice, Santoni, Angela, Paolini, Rossella
Publicado em 2014

Lipid Raft-Dependent FcεRI Ubiquitination Regulates Receptor Endocytosis through the Action of Ubiquitin Binding Adaptors

Por Molfetta, Rosa, Gasparrini, Francesca, Peruzzi, Giovanna, Vian, Laura, Piccoli, Mario, Frati, Luigi, Santoni, Angela, Paolini, Rossella
Publicado em 2009

Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation

Por Fionda, Cinzia, Abruzzese, Maria Pia, Zingoni, Alessandra, Soriani, Alessandra, Ricci, Biancamaria, Molfetta, Rosa, Paolini, Rossella, Santoni, Angela, Cippitelli, Marco
Publicado no BMC Cancer (2015)

Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production

Por Capuano, Cristina, Pighi, Chiara, Molfetta, Rosa, Paolini, Rossella, Battella, Simone, Palmieri, Gabriella, Giannini, Giuseppe, Belardinilli, Francesca, Santoni, Angela, Galandrini, Ricciarda
Publicado no Oncoimmunology (2017)

Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination

Por Ferreri, Andrés J. M., Licata, Giada, Foppoli, Marco, Corazzelli, Gaetano, Zucca, Emanuele, Stelitano, Caterina, Zaja, Francesco, Fava, Sergio, Paolini, Rossella, Franzin, Alberto, Politi, Letterio S., Ponzoni, Maurilio, Reni, Michele
Publicado em 2011

The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma

Por Fionda, Cinzia, Abruzzese, Maria Pia, Zingoni, Alessandra, Cecere, Francesca, Vulpis, Elisabetta, Peruzzi, Giovanna, Soriani, Alessandra, Molfetta, Rosa, Paolini, Rossella, Ricciardi, Maria Rosaria, Petrucci, Maria Teresa, Santoni, Angela, Cippitelli, Marco
Publicado no Oncotarget (2015)

Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role...

Por Abruzzese, Maria Pia, Bilotta, Maria Teresa, Fionda, Cinzia, Zingoni, Alessandra, Soriani, Alessandra, Vulpis, Elisabetta, Borrelli, Cristiana, Zitti, Beatrice, Petrucci, Maria Teresa, Ricciardi, Maria Rosaria, Molfetta, Rosa, Paolini, Rossella, Santoni, Angela, Cippitelli, Marco
Publicado no J Hematol Oncol (2016)

p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells

Por Soriani, Alessandra, Borrelli, Cristiana, Ricci, Biancamaria, Molfetta, Rosa, Zingoni, Alessandra, Fionda, Cinzia, Carnevale, Silvia, Abruzzese, Maria Pia, Petrucci, Maria Teresa, Ricciardi, Maria Rosaria, La Regina, Giuseppe, Di Cesare, Erica, Lavia, Patrizia, Silvestri, Romano, Paolini, Rossella, Cippitelli, Marco, Santoni, Angela
Publicado no Oncoimmunology (2016)

Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70/TLR2/NF-kB axis

Por Vulpis, Elisabetta, Cecere, Francesca, Molfetta, Rosa, Soriani, Alessandra, Fionda, Cinzia, Peruzzi, Giovanna, Caracciolo, Giulio, Palchetti, Sara, Masuelli, Laura, Simonelli, Lucilla, D'Oro, Ugo, Abruzzese, Maria Pia, Petrucci, Maria Teresa, Ricciardi, Maria Rosaria, Paolini, Rossella, Cippitelli, Marco, Santoni, Angela, Zingoni, Alessandra
Publicado no Oncoimmunology (2017)

Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia

Por Perbellini, Omar, Falisi, Erika, Giaretta, Ilaria, Boscaro, Elisa, Novella, Elisabetta, Facco, Monica, Fortuna, Stefania, Finotto, Silvia, Amati, Eliana, Maniscalco, Francesco, Montaldi, Anna, Alghisi, Alberta, Aprili, Fiorenza, Bonaldi, Laura, Paolini, Rossella, Scupoli, Maria Teresa, Trentin, Livio, Ambrosetti, Achille, Semenzato, Gianpietro, Pizzolo, Giovanni, Rodeghiero, Francesco, Visco, Carlo
Publicado em 2014

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia

Por Moreno, Carol, Montillo, Marco, Panayiotidis, Panayiotis, Dimou, Maria, Bloor, Adrian, Dupuis, Jehan, Schuh, Anna, Norin, Stefan, Geisler, Christian, Hillmen, Peter, Doubek, Michael, Trněný, Marek, Obrtlikova, Petra, Laurenti, Luca, Stilgenbauer, Stephan, Smolej, Lukas, Ghia, Paolo, Cymbalista, Florence, Jaeger, Ulrich, Stamatopoulos, Kostas, Stavroyianni, Niki, Carrington, Patrick, Zouabi, Hamadi, Leblond, Veronique, Gomez-Garcia, Juan C., Rubio, Martin, Marasca, Roberto, Musuraca, Gerardo, Rigacci, Luigi, Farina, Lucia, Paolini, Rossella, Pospisilova, Sarka, Kimby, Eva, Bradley, Colm, Montserrat, Emili
Publicado no Haematologica (2015)